🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
To assess the safety and tolerability at increasing dose levels of PF-06863...
Status
Completed
Location
UCSD Medical Center - Encinitas
Start Date
2017-11-29
Trial ID
NCT03269136
The objective of this study is to determine whether pomalidomide is safe an...
Status
Completed
Location
Mayo Clinic
Start Date
2010-09-08
Trial ID
NCT01178281
Treatments Being Tested
PMS period: 09Jun2017 \~ 08Jun2023 Target no.: 600patients indication: POM...
Status
Completed
Location
Korea University Ansan Hospital
Start Date
2017-12-28
Trial ID
NCT03288974
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of ixazomi...
Status
Unknown
Location
PekingUMCH
Start Date
2021-07-26
Trial ID
NCT04989140
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose and ef...
Status
Completed
Location
Mayo Clinic Arizona
Start Date
2008-06
Trial ID
NCT00833833
Treatments Being Tested
The purpose of this study is to test safety and anti-tumor activity of BT06...
Status
Completed
Location
City of Hope
Start Date
2012-07-03
Trial ID
NCT01638936
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability, maximum...
Status
Completed
Location
City of Hope - Duarte
Start Date
2018-04-20
Trial ID
NCT03439280
Treatments Being Tested
Patients with multiple myeloma (a type of blood cancer affecting the white ...
Status
Completed
Location
Princess Margaret Cancer Centre
Start Date
2020-07-03
Trial ID
NCT03959358
Treatments Being Tested
Based on the need to improve outcomes post second autologous stem cell tran...
Status
Active Not Recruiting
Location
Colorado Blood Cancer Institute (Sarah Cannon)
Start Date
2017-11-22
Trial ID
NCT03030261
Treatments Being Tested